Table 4: Drug treatment plan and application.


Drugs FDA approval Dosage Application methods

MPA FDA approved 4 x 250mg/daily/ 6 month Oral
Doxorubicin FDA approved 60 mg/m 2/21day/5 cycle intravenous
Docetaxel FDA approved 75 mg/m 2/21day/5 cycle intravenous
Cyclophosphamide FDA approved 500 mg/m 2/21 day/2 cycle Intravenous